Learn More
Medchemexpress LLC Tranylcypromine hemisulfate | 13492-01-8 | 99.9% | 1 ML

Supplier: Medchemexpress LLC HYB149610MM/1ML
Tranylcypromine hemisulfate is an irreversible, nonselective monoamine oxidase (MAO) inhibitor used in the treatment of depression. It also acts as a lysine-specific demethylase 1 (LSD1) inhibitor, capable of suppressing lesion growth and ameliorating generalized hyperalgesia in mouse models of induced endometriosis. This compound exhibits antidepressant effects.
- Irreversible, nonselective monoamine oxidase (MAO) inhibitor.
- Lysine-specific demethylase 1 (LSD1) inhibitor.
- Suppresses lesion growth and ameliorates generalized hyperalgesia.
- Neuroprotective against human Aβ(1-42) oligomer-induced toxicity.
- Protects RGCs from glutamate neurotoxicity-induced apoptosis and oxidative stress.
- Promotes mitogen-activated protein kinase 12 (p38 MAPKγ) expression.
- Enhances RGC survival by attenuating NMDA neurotoxicity.
- Increases cell proliferation in brain regions.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.